Opus Genetics (IRD) Share-based Compensation (2010 - 2026)
Opus Genetics' Share-based Compensation was $1.41 million in Q2 2026, up 57.0% from $896,000 a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Opus Genetics' Share-based Compensation was $3.65 million through Jun 30, 2026, up 40.0% year-over-year; for FY2025, it came in at $3.4 million, up 1.1% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 17.7% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $3.36 million in FY2024 (-4.2%), $3.51 million in FY2023 (+94.2%), $1.81 million in FY2022 (-5.6%) and $1.91 million in FY2021 (+27.1%).
- Quarterly Share-based Compensation has moved between $26,000 (Q3 2021) and $247 million (Q1 2023) over five years.
- Compared with a year earlier, Share-based Compensation was higher in three of the last five quarters, with growth averaging 23.8%.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2022 (growth of 280.8%); the worst was Q1 2024 (a decline of 99.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Opus Genetics | 381.93 Mn | 157.22 Mn | - | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 774,000.00 |
| Sep 30, 2025 | 816,000.00 |
| Jun 30, 2025 | 896,000.00 |
| Mar 31, 2025 | 913,000.00 |
| Dec 31, 2024 | 795,000.00 |
| Sep 30, 2024 | 776,000.00 |
| Jun 30, 2024 | 806,000.00 |
| Mar 31, 2024 | 985,000.00 |
| Dec 31, 2023 | 711,000.00 |
| Sep 30, 2023 | 573,000.00 |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 247.00 Mn |
| Dec 31, 2022 | 424,000.00 |
| Sep 30, 2022 | 493,000.00 |
| Jun 30, 2022 | 445,000.00 |
| Mar 31, 2022 | 445,000.00 |
| Dec 31, 2021 | 479,000.00 |
| Sep 30, 2021 | 478,000.00 |
API Access
Opus Genetics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();